Cargando…

Improved SARS-CoV-2 M(pro) inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies

Replication of SARS-CoV-2, the coronavirus causing COVID-19, requires a main protease (M(pro)) to cleave viral proteins. Consequently, M(pro) is a target for antiviral agents. We and others previously demonstrated that GC376, a bisulfite prodrug with efficacy as an anti-coronaviral agent in animals,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vuong, Wayne, Fischer, Conrad, Khan, Muhammad Bashir, van Belkum, Marco J., Lamer, Tess, Willoughby, Kurtis D., Lu, Jimmy, Arutyunova, Elena, Joyce, Michael A., Saffran, Holly A., Shields, Justin A., Young, Howard S., Nieman, James A., Tyrrell, D. Lorne, Lemieux, M. Joanne, Vederas, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164773/ https://www.ncbi.nlm.nih.gov/pubmed/34118724 http://dx.doi.org/10.1016/j.ejmech.2021.113584

Ejemplares similares

N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M(pro) Dimer
por: Arutyunova, Elena, et al.
Publicado: (2021)

Crystallization of Feline Coronavirus M(pro) With GC376 Reveals Mechanism of Inhibition
por: Lu, Jimmy, et al.
Publicado: (2022)

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Vuong, Wayne, et al.
Publicado: (2020)

Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Vuong, Wayne, et al.
Publicado: (2020)

Structure basis for inhibition of SARS-CoV-2 by the feline drug GC376
por: Luan, Xiao-dong, et al.
Publicado: (2022)

Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
por: Sharun, Khan, et al.
Publicado: (2020)

Author Correction: Structure basis for inhibition of SARS-CoV-2 by the feline drug GC376
por: Luan, Xiao-dong, et al.
Publicado: (2022)

SARS-CoV-2 M(pro) Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals
por: Chen, Sizhu Amelia, et al.
Publicado: (2023)

Simplified cloning and isolation of peptides from “sandwiched” SUMO-peptide-intein fusion proteins
por: Lamer, Tess, et al.
Publicado: (2023)

Effect of GS-441524 in combination with the 3C-like protease inhibitor GC376 on the treatment of naturally transmitted feline infectious peritonitis
por: Lv, Jinbao, et al.
Publicado: (2022)

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir
por: Paciaroni, Alessandro, et al.
Publicado: (2023)

SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1
por: Law, John Lok Man, et al.
Publicado: (2021)

Interaction of GC376, a SARS-COV-2 M(PRO) inhibitor, with model lipid membranes
por: Klacsová, Mária, et al.
Publicado: (2022)

A cysteine protease inhibitor GC376 displays potent antiviral activity against coxsackievirus infection
por: Chen, Yongkang, et al.
Publicado: (2023)

MINOS: Bt 376 - 599 ext - 376 ext - AP (100)
Publicado: (1991)

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
por: Fu, Lifeng, et al.
Publicado: (2020)

Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions
por: Wang, Yining, et al.
Publicado: (2022)

Structural Basis for Inhibiting Porcine Epidemic Diarrhea Virus Replication with the 3C-Like Protease Inhibitor GC376
por: Ye, Gang, et al.
Publicado: (2020)

Travaux au bâtiment 376
Publicado: (1992)

Aggregation of M3 (E376D) variant of alpha1- antitrypsin
por: Bashir, Arif, et al.
Publicado: (2020)

Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture
por: Hu, Yanmei, et al.
Publicado: (2020)

The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro
por: Gidari, Anna, et al.
Publicado: (2022)

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
por: Ma, Chunlong, et al.
Publicado: (2020)

The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract
por: Shi, Yuejun, et al.
Publicado: (2021)

Micellar Antibiotics of Bacillus
por: Ferreira, William T., et al.
Publicado: (2021)

Facade repair works on building 376
Publicado: (2003)

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
por: Ma, Chunlong, et al.
Publicado: (2020)

Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
por: Cáceres, C. Joaquín, et al.
Publicado: (2021)

MED12/376: Microbiology and the Hospital Intranet
por: Perera, B
Publicado: (1999)

Draft Genome Sequences of Paenibacillus polymyxa NRRL B-30509 and Paenibacillus terrae NRRL B-30644, Strains from a Poultry Environment That Produce Tridecaptin A and Paenicidins
por: van Belkum, Marco J., et al.
Publicado: (2015)

SARS-CoV-2 3CL(pro) mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376
por: Heilmann, Emmanuel, et al.
Publicado: (2022)

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir
por: Xia, Zilei, et al.
Publicado: (2021)

P376: Dirty bedpans and MDRO: partners in crime?
por: Van Knippenberg-Gordebeke, GG
Publicado: (2013)

Feline leucocyte antigen class II polymorphism and susceptibility to feline infectious peritonitis
por: Addie, Diane D, et al.
Publicado: (2004)

Colloidal dispersions and micellar behavior
por: Mittal, K L
Publicado: (1975)

Micellar formation of cationic surfactants
por: Sharker, Komol Kanta, et al.
Publicado: (2019)

Is Micellar Catalysis Green Chemistry?
por: Fabris, Fabrizio, et al.
Publicado: (2023)

Interaction of Caffeic Acid with SDS Micellar Aggregates
por: Cid, Antonio, et al.
Publicado: (2019)

Biological Activity and Photostability of Biflorin Micellar Nanostructures
por: Santana, Edson R. B., et al.
Publicado: (2015)

Violin sonatas K 378, K 376 & K 296
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_5v4rfgunl47d8nadf3ivfq5v4l